About Verscend
Verscend is a Healthcare company based in Waltham (United States) founded in 1996, and was acquired by Veritas Capital in April 2016. Healthcare data analytics and risk assessment solutions are provided. Verscend has raised $15 million across 1 funding round from investors including Veritas Capital and ISO. Verscend has completed 2 acquisitions, including Cotiviti and HealthCare Insight. Its chief executive, as recorded, is Emad Rizk. Verscend offers products and services including Payment Accuracy, Risk Adjustment, Quality and Performance, and Consumer Engagement. Its focus areas include HealthTech, Healthcare Payer Tech, Claims Management and Claims Data Insights. Its legal entity is Cotiviti, Inc. Its competitors include Ribbon Health, Prognos Health and PurpleLab; 3 of its 3 listed competitors have raised funding.
Company details
Verscend was founded in 1996 and is based in Waltham, United States. Healthcare data analytics solutions are offered, including population health analytics with DxCG Intelligence for risk adjustment and predictive modeling. Payment accuracy services encompass cost containment, online fraud monitoring, Medicare and commercial risk adjustment, and quality improvement for HEDIS compliance. Medical record retrieval and abstraction solutions are also provided to support payers.
- Headquarters Waltham, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website verscend.com
- Social LinkedIn X Facebook YouTube
- Acquired by Veritas Capital (Apr 2016)
- Legal Name Cotiviti, Inc
- Total Equity Funding$15M (USD)
in 1 rounds
- Latest Funding Round$15M (USD), Series B
Jul 2006
- InvestorsVeritas Capital
& 1 more
- Investments & AcquisitionsCotiviti
& 1 more
- Acquired by
Products & Services of Verscend
Verscend offers a comprehensive portfolio of products and services, including Payment Accuracy, Risk Adjustment, Quality and Performance, and Consumer Engagement.
Tools for accurate claim validation and payment integrity.
Solutions for ensuring proper reimbursement through data analysis.
Services to improve clinical and financial performance metrics.
Platforms for driving member actions and health outcomes.
Apps and channels of Verscend
its YouTube channel Cotiviti has 1.09K subscribers and 30 videos.
Videos from Verscend
The most watched videos on Verscend's YouTube channel, Cotiviti (1.09K subscribers). Click a video to play it here.
More on Cotiviti.
Funding Insights of Verscend
Verscend has successfully raised a total of $15M through 1 strategic funding round. The most recent funding activity was a Series B round of $15 million completed in July 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15M
- Total Rounds 1
- Last Round Series B — $15M
- First Round $15M
(Jul 2006)
All 1 funding rounds of Verscend with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2006 | $15M | Series B | – | – | – |
2 investors in total: 2 institutional.
Investors in Verscend
Verscend has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Veritas Capital and ISO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Technology enterprises are targeted for private equity investments. | 1992 | veritascapital.com | New York, United States | |
International standards are developed and coordinated worldwide. | 1946 | iso.org | Geneva, Switzerland |
Investor details for Verscend
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Verscend
1 people are tracked at Verscend (1 in leadership).
| Name | Role | Group |
|---|---|---|
Emad Rizk | CEO & President | Leadership |
Complete people profiles for Verscend
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Verscend
Verscend has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cotiviti and HealthCare Insight.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Analytics-driven payment accuracy solutions for healthcare payers are provided. | cotiviti.com | Atlanta, United States | 1979 | Jun 2018 | $4.9B | |
SaaS software detects and prevents healthcare fraud, abuse, and overpayments. | hcinsight.com | South Jordan, United States | 1997 | Oct 2007 | •••• |
Complete acquisition details for Verscend
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Verscend
6 dated milestones of Verscend across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Verscend is founded.
- Exit Acquired by ISO.
- Funding First funding round of $15.0M.
- Acquisition Acquires HealthCare Insight.
- Exit Acquired by Veritas Capital.
- Acquisition Acquires Cotiviti.
Competitors of Verscend
Verscend has 3 listed competitors in our database, 3 of them funded. They include Ribbon Health, Prognos Health and PurpleLab.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ribbonhealth.com | 2016 | New York, United States | $55.64M | Predictive analytics platform is provided for healthcare providers. | ||
| prognoshealth.com | 2010 | New York, United States | $73.51M | 50 | AI-based platform for clinical data sharing and management is provided. | |
| purplelab.com | 2016 | Furlong, United States | $43M | Healthcare analytics solutions for healthcare stakeholders |
Detailed competitors of Verscend
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Verscend
The website of Verscend (verscend.com) receives about 1.2K visits a month.
- Monthly visits1.2K
▲ 80.5% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Verscend (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Verscend
Complete news archive for Verscend
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Verscend
Verscend was founded in 1996 and raised its 1st funding round 10 years after it was founded.
Verscend is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
Emad Rizk is the CEO of Verscend, as recorded in our data.
Verscend is a funded company, having raised a total of $15M across 1 funding round to date. The company's 1st funding round was a Series B of $15M, raised on Jul 2006.
Verscend was founded in 1996 and is based in Waltham, United States. Healthcare data analytics solutions are offered, including population health analytics with DxCG Intelligence for risk adjustment and predictive modeling. Payment accuracy services encompass cost containment, online fraud monitoring, Medicare and commercial risk adjustment, and quality improvement for HEDIS compliance. Medical record retrieval and abstraction solutions are also provided to support payers.
Verscend's top competitors include Ribbon Health, Prognos Health and PurpleLab.
Verscend offers Payment Accuracy, Risk Adjustment, Quality and Performance, and Consumer Engagement.
Verscend has made 2 acquisitions, including Cotiviti, and HealthCare Insight.
Verscend has 2 investors. Key investors include Veritas Capital, and ISO.
Verscend operates through Cotiviti, Inc.
Yes. Verscend was acquired by Veritas Capital in April 2016.